title: Vasoactive intestinal peptide increases hepatic transduction and reduces innate immune response following administration of helper-dependent Ad.
abstract: Helper-dependent adenoviral vectors (HDAd) are effective tools for liver-directed gene therapy because they can mediate long-term transgene expression in the absence of chronic toxicity. However, high vector doses required for efficient hepatocyte transduction by intravascular delivery result in systemic vector dissemination and dose-dependent activation of the innate immunity. Therefore, strategies to achieve high-efficiency hepatocyte transduction using low vector doses and/or to reduce the acute elevations of proinflammatory cytokines and chemokines may have significant clinical potential. Vasoactive intestinal peptide (VIP) is an endogenous neuropeptide involved in the regulation of hepatic blood flow and plays an important role as modulator of immune functions. Here, we show that VIP pretreatment in mice is able to increase hepatocyte transduction by HDAd, decrease vector uptake by the spleen, reduce elevation of proinflammatory serum cytokines interleukin (IL)-6 and IL-12, and reduce serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) following intravenous HDAd injection. VIP pretreatment also resulted in a reduction in the expression of the chemokines macrophage-inflammatory protein 2 (MIP-2), monocyte chemotactic protein 1 (MCP-1), and regulated on activation normal T-cell expressed and secreted (RANTES) in the livers of mice injected with HDAd. These results suggest that VIP can improve the therapeutic index of HDAd by increasing hepatocyte transduction efficiency while reducing cytokine and chemokine expression following intravascular delivery of HDAd.
authors.affiliation: Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA.
authors.forename: Francesco
authors.initials: F
authors.lastname: Vetrini
authors.forename: Nicola
authors.initials: N
authors.lastname: Brunetti-Pierri
authors.forename: Donna J
authors.initials: DJ
authors.lastname: Palmer
authors.forename: Terry
authors.initials: T
authors.lastname: Bertin
authors.forename: Nathan C
authors.initials: NC
authors.lastname: Grove
authors.forename: Milton J
authors.initials: MJ
authors.lastname: Finegold
authors.forename: Philip
authors.initials: P
authors.lastname: Ng
mesh_terms: D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D016207:Cytokines / Q000378:metabolism; D005822:Genetic Vectors / Q000008:administration & dosage* / Q000235:genetics; D018664:Interleukin-12 / Q000378:metabolism; D008099:Liver / Q000187:drug effects* / Q000378:metabolism*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D016133:Polymerase Chain Reaction; D013154:Spleen / Q000187:drug effects / Q000378:metabolism; D014161:Transduction, Genetic; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology*
chemical_list: D016207:Cytokines; D018664:Interleukin-12; D014660:Vasoactive Intestinal Peptide
references.citation: Curr Gene Ther. 2009 Oct;9(5):329-40
references.pmid: 19860648
references.citation: Gastroenterology. 1981 Aug;81(2):356-75
references.pmid: 6113188
references.citation: Cephalalgia. 2006 Aug;26(8):992-1003
references.pmid: 16886936
references.citation: Gastroenterology. 2003 Apr;124(4):961-71
references.pmid: 12671893
references.citation: Cold Spring Harb Protoc. 2011 Jul 01;2011(7):867-70
references.pmid: 21724820
references.citation: Mol Ther. 2009 Feb;17(2):327-33
references.pmid: 19050700
references.citation: J Immunol. 2008 Apr 1;180(7):4931-8
references.pmid: 18354218
references.citation: Hum Gene Ther. 1999 Oct 10;10(15):2515-26
references.pmid: 10543616
references.citation: J Immunol. 2000 Sep 15;165(6):3051-7
references.pmid: 10975815
references.citation: Mol Ther. 2005 Jul;12(1):99-106
references.pmid: 15963925
references.citation: Mol Ther. 2001 May;3(5 Pt 1):697-707
references.pmid: 11356075
references.citation: J Immunol. 2006 Nov 1;177(9):5920-7
references.pmid: 17056516
references.citation: Hum Gene Ther. 1999 Apr 10;10(6):965-76
references.pmid: 10223730
references.citation: Ann N Y Acad Sci. 2006 Jul;1070:190-5
references.pmid: 16888164
references.citation: J Leukoc Biol. 2005 Aug;78(2):491-502
references.pmid: 15857940
references.citation: Hum Gene Ther. 2002 Jan 1;13(1):143-54
references.pmid: 11779418
references.citation: Arthritis Res Ther. 2005;7(5):R1034-45
references.pmid: 16207319
references.citation: J Virol. 2004 Jun;78(11):5966-72
references.pmid: 15140994
references.citation: Eur J Immunol. 2000 Nov;30(11):3236-46
references.pmid: 11093139
references.citation: Hum Gene Ther. 2006 Mar;17(3):264-79
references.pmid: 16544976
references.citation: Mol Ther. 2003 Nov;8(5):846-52
references.pmid: 14599819
references.citation: Gene Ther. 2007 Apr;14(7):604-12
references.pmid: 17235290
references.citation: Immunol Invest. 2005;34(2):153-69
references.pmid: 15921157
references.citation: Clin Hemorheol Microcirc. 2000;23(2-4):85-94
references.pmid: 11321464
references.citation: Mol Ther. 2007 Apr;15(4):732-40
references.pmid: 17285138
references.citation: Arch Physiol Biochem. 2001 Oct;109(4):377-82
references.pmid: 11935377
references.citation: Hum Gene Ther. 2006 Apr;17(4):391-404
references.pmid: 16610927
references.citation: Hum Gene Ther. 2004 Jan;15(1):35-46
references.pmid: 14965376
references.citation: Res Exp Med (Berl). 1986;186(2):151-65
references.pmid: 2872707
references.citation: Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):1053-8
references.pmid: 11792830
references.citation: Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13282-7
references.pmid: 11687662
references.citation: Peptides. 2008 Jun;29(6):948-56
references.pmid: 18359536
references.citation: J Virol. 2000 May;74(9):3941-7
references.pmid: 10756005
references.citation: Viral Immunol. 1992 Fall;5(3):195-200
references.pmid: 1418317
references.citation: Digestion. 2002;66(3):186-92
references.pmid: 12481165
references.citation: J Neuroimmunol. 2000 Oct 2;110(1-2):97-105
references.pmid: 11024538
references.citation: Gene Ther. 2004 Oct;11(20):1523-31
references.pmid: 15269718
references.citation: Mol Ther. 2001 May;3(5 Pt 1):708-22
references.pmid: 11356076
references.citation: J Biol Chem. 2001 Jan 5;276(1):369-80
references.pmid: 11029467
references.citation: Biochem Biophys Res Commun. 2003 Mar 7;302(2):275-83
references.pmid: 12604342
references.citation: Mol Ther. 2008 May;16(5):931-41
references.pmid: 18388926
references.citation: Comp Hepatol. 2002 Aug 23;1(1):1
references.pmid: 12437787
references.citation: Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):3930-5
references.pmid: 15753292
references.citation: Mol Ther. 2004 Oct;10(4):792-8
references.pmid: 15451463
references.citation: J Immunol. 2007 Feb 1;178(3):1767-73
references.pmid: 17237426
references.citation: Hum Gene Ther. 2005 Jul;16(7):811-20
references.pmid: 16000063
references.citation: J Virol. 2004 May;78(10):5368-81
references.pmid: 15113916